학술논문
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Document Type
Article
Author
Source
In: Breast Cancer Research . (Breast Cancer Research, 15 March 2012, 14(2))
Subject
Language
English
ISSN
14655411
1465542X
1465542X